Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 22, 2018

DrugPatentWatch Database Preview

Hydralazine hydrochloride; hydrochlorothiazide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydralazine hydrochloride; hydrochlorothiazide and what is the scope of hydralazine hydrochloride; hydrochlorothiazide patent protection?
Hydralazine hydrochloride; hydrochlorothiazide is the generic ingredient in twenty-one branded drugs marketed by Novartis, Par Pharm, Solvay, Superpharm, Watson Labs, Ivax Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Sandoz, Sun Pharm Industries, and Lederle, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for hydralazine hydrochloride; hydrochlorothiazide.

Summary for hydralazine hydrochloride; hydrochlorothiazide

US Patents:	0
Tradenames:	21
Applicants:	12
NDAs:	36
Drug Master File Entries:	20
Bulk Api Vendors:	1
Clinical Trials:	3
DailyMed Link:	hydralazine hydrochloride; hydrochlorothiazide at DailyMed

Synonyms for hydralazine hydrochloride; hydrochlorothiazide

C8H8N4.C7H8ClN3O4S2.HCl
LS-178474
SCHEMBL9374288

US Patents and Regulatory Information for hydralazine hydrochloride; hydrochlorothiazide

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Solvay	HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydralazine hydrochloride; hydrochlorothiazide	CAPSULE;ORAL	087213-001	Feb 8, 1982		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Ivax Sub Teva Pharms	HYDROSERPINE PLUS (R-H-H)	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	083877-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Solvay	RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	088376-001	Oct 28, 1983		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Watson Labs	HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE	hydralazine hydrochloride; hydrochlorothiazide; reserpine	TABLET;ORAL	083770-001	Approved Prior to Jan 1, 1982		DISCN	No	No	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca

Moodys

QuintilesIMS

Covington

Julphar

UBS

Federal Trade Commission

Baxter

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.